These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34949699)

  • 21. Percentage of low attenuation area on computed tomography detects chronic lung allograft dysfunction, especially bronchiolitis obliterans syndrome, after bilateral lung transplantation.
    Kubo Y; Sugimoto S; Shiotani T; Matsubara K; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Toyooka S
    Clin Transplant; 2023 Nov; 37(11):e15077. PubMed ID: 37461238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of biomechanical anatomical modeling via computed tomography for identification of restrictive allograft syndrome.
    Horie M; Saito T; Moseley J; D'Errico L; Salazar P; Nakajima D; Brock K; Yasufuku K; Binnie M; Keshavjee S; Paul N
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28658530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?
    Verleden GM; Godinas L; Vos R; Verleden SE
    Curr Opin Organ Transplant; 2022 Jun; 27(3):211-216. PubMed ID: 35649111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung Density Analysis Using Quantitative Chest CT for Early Prediction of Chronic Lung Allograft Dysfunction.
    Horie M; Levy L; Houbois C; Salazar P; Saito T; Pakkal M; OʼBrien C; Sajja S; Brock K; Yasufuku K; Keshavjee S; Paul N; Martinu T
    Transplantation; 2019 Dec; 103(12):2645-2653. PubMed ID: 31343572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional and computed tomographic evolution and survival of restrictive allograft syndrome after lung transplantation.
    Verleden SE; de Jong PA; Ruttens D; Vandermeulen E; van Raemdonck DE; Verschakelen J; Vanaudenaerde BM; Verleden GM; Vos R
    J Heart Lung Transplant; 2014 Mar; 33(3):270-7. PubMed ID: 24461432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
    Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic Lung Allograft Dysfunction.
    Venado A; Kukreja J; Greenland JR
    Thorac Surg Clin; 2022 May; 32(2):231-242. PubMed ID: 35512941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiographic Graft Surveillance in Lung Transplantation: Prognostic Role of Parametric Response Mapping.
    Belloli EA; Gu T; Wang Y; Vummidi D; Lyu DM; Combs MP; Chughtai A; Murray S; Galbán CJ; Lama VN
    Am J Respir Crit Care Med; 2021 Oct; 204(8):967-976. PubMed ID: 34319850
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of Transplant Body Mass Index and Post-Transplant Weight Changes on the Development of Chronic Lung Allograft Dysfunction Phenotypes.
    Beauchamp-Parent C; Jomphe V; Morisset J; Poirier C; Lands LC; Nasir BS; Ferraro P; Mailhot G
    Transplant Proc; 2024; 56(6):1420-1428. PubMed ID: 38991901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
    Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
    J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of chronic lung allograft dysfunction using ventilation-weighted Fourier decomposition MRI.
    Voskrebenzev A; Greer M; Gutberlet M; Schönfeld C; Renne J; Hinrichs J; Kaireit T; Welte T; Wacker F; Gottlieb J; Vogel-Claussen J
    Am J Transplant; 2018 Aug; 18(8):2050-2060. PubMed ID: 29607606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C; Haughton M; Leonard S; Huber LC
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
    Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
    Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
    [No Abstract]   [Full Text] [Related]  

  • 34. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction.
    Wong W; Johnson B; Cheng PC; Josephson MB; Maeda K; Berg RA; Kawut SM; Harhay MO; Goldfarb SB; Yehya N; Himebauch AS
    J Heart Lung Transplant; 2023 May; 42(5):669-678. PubMed ID: 36639317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early chest CT abnormalities to predict the subsequent occurrence of chronic lung allograft dysfunction.
    Habert P; Chetrit E; Coiffard B; Bregeon F; Thomas P; Loundou A; Bermudez J; Reynaud-Gaubert M; Gaubert JY
    Insights Imaging; 2023 Sep; 14(1):154. PubMed ID: 37741923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrum of chronic lung allograft dysfunction pathology in human lung transplantation.
    Renaud-Picard B; Berra G; Hwang D; Huszti E; Miyamoto E; Berry GJ; Pal P; Juvet S; Keshavjee S; Martinu T
    J Heart Lung Transplant; 2024 Oct; 43(10):1701-1715. PubMed ID: 38663465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
    Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
    J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
    Gottlieb J; Verleden GM; Perchl M; Valtin C; Vallee A; Brugière O; Bravo C
    PLoS One; 2021; 16(12):e0260881. PubMed ID: 34941934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.
    Todd JL; Jain R; Pavlisko EN; Finlen Copeland CA; Reynolds JM; Snyder LD; Palmer SM
    Am J Respir Crit Care Med; 2014 Jan; 189(2):159-66. PubMed ID: 24325429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.